Literature DB >> 9704647

Radiographic progression in rheumatoid arthritis: a long-term prospective study of 109 patients.

N A Graudal1, A G Jurik, A de Carvalho, H K Graudal.   

Abstract

OBJECTIVE: To investigate the long-term radiographic course as a mathematical function of disease duration in individual patients and in a group of patients with rheumatoid arthritis (RA).
METHODS: In 109 patients with RA, radiographic examinations of 46 diarthrodial joints were performed at regular intervals of 1-3 years, for up to 30 years after disease onset.
RESULTS: Five main types of progression were identified: 1) a rare type (<1%), with no radiographic progression at all; 2) a type with a slow or moderate onset, but an increasing progression rate (9% exponential growth type and 30% linear type); 3) a type with a moderate-to-fast onset and a stable progression rate (the square-root type; 11%); 4) a type with a fast onset, but a later decreasing progression rate (the first-order kinetics type, 30%); and 5) a type characterized by slow onset, then acceleration and later deceleration (the sigmoid type, 20%).
CONCLUSION: The progression of radiographic damage in RA followed mathematical functions of time. The identification of progression type may be used in the prediction of outcome in patients with RA.

Entities:  

Mesh:

Year:  1998        PMID: 9704647     DOI: 10.1002/1529-0131(199808)41:8<1470::AID-ART18>3.0.CO;2-V

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

1.  Ultrasonography in the evaluation of bone erosions.

Authors:  W Grassi; E Filippucci; A Farina; F Salaffi; C Cervini
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

2.  Dynamic exercises in patients with rheumatoid arthritis.

Authors:  A P Anandarajah; E M Schwarz
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

3.  Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis.

Authors:  Jie Zhang; David T Redden; Gerald McGwin; Leigh F Callahan; Edwin A Smith; Graciela S Alarcón; Larry W Moreland; Désirée M van der Heijde; Elizabeth E Brown; Donna K Arnett; Ted R Mikuls; S Louis Bridges
Journal:  Arthritis Rheum       Date:  2010-08

4.  Severity of rheumatoid arthritis: the SEVERA study.

Authors:  Rafic Baddoura; Souha Haddad; Hassane Awada; Abdel Fattah Al-Masri; Georges Merheb; Said Attoui; Jad Okais; Jamil Messayke; Fadi Ghandour
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

5.  Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis.

Authors:  Xiaoyan Zhao; Ferhan Qureshi; P Scott Eastman; William C Manning; Claire Alexander; William H Robinson; Lyndal K Hesterberg
Journal:  J Immunol Methods       Date:  2012-02-17       Impact factor: 2.303

Review 6.  Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents.

Authors:  Rolf Rau
Journal:  Clin Rheumatol       Date:  2004-07-24       Impact factor: 2.980

7.  Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome.

Authors:  N A Graudal; M Svenson; U Tarp; P Garred; A-G Jurik; K Bendtzen
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

8.  Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis.

Authors:  E Lindqvist; K Jonsson; T Saxne; K Eberhardt
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

9.  Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.

Authors:  Theresa Kapral; Tanja Stamm; Klaus P Machold; Karin Montag; Josef S Smolen; Daniel Aletaha
Journal:  Arthritis Res Ther       Date:  2006-02-24       Impact factor: 5.156

Review 10.  Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials.

Authors:  Niels Graudal; Thorbjørn Hubeck-Graudal; Simon Tarp; Robin Christensen; Gesche Jürgens
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.